Report Categories
View AllRecent Articles
View All
How CreativeMed CELZ prepares for market disruptions Q3 2025 Earnings Beat Estimates
BAM Brookfield AM posts Q4 2025 six percent EPS beat shares slip slightly on mild investor caution
How sustainable is Neuphoria Therapeutics NEUP earnings momentum Q1 2026 Better Than Expected
The growth story Life360 LIF is not telling investors Tick Down 20260506
Wolfspeed WOLF Q1 2026 Earnings Miss EPS 326 vs 206 Expected
Trump Drops IRS Lawsuit Opens Door to 10 Billion Tax Return Leak Settlement
Archimedes ATIIW Jumps 641 on Strong Momentum 20260515
Otis College OLaunch Exhibition Highlights Emerging Creative Talent Signals Growth in Design Economy
Consolidated Edison ED Stock Today Drops 170 Key Support at 10098 20260520
Wen WENN Stalls at 1026 Breakout or Breakdown 20260520
Nigerias Arrest of Former Power Minister Signals AntiCorruption Drive May Impact Investor Sentiment
Regis Corporation RGS Q1 2026 Results Meet Expectations Revenue NA
Market Complacency Raises Concerns Analysts Warn of Potential Downturn
Iran and US Explore 60Day Nuclear Deal Uranium Enrichment Sanctions Relief and Frozen Funds on Table
SpaceX IPO High Valuation Raises Questions Amid Hype and Achievement
Nifty 50s LongTerm Performance Sends Reassuring Signal to FPIs Amid Current Challenges
Bernstein Bullish on Indian Pharma Sees Up to 40 Upside in Six Stocks
Nvidia Stock Approaches Critical Technical Level Analysts Eye Potential Breakout or Breakdown
Faraday Future Intelligent Electric Inc Q1 2026 Earnings EPS Surprise Positive but Revenue Remains Elusive Stock Drops
Pearl Diver Credit Company Inc 800 Series A Preferred Stock Due 2029 PDPA Q4 2025 Earnings Preferred EPS Misses Estimates as Credit Market Headwinds Emerge
Rapid7 RPD Q1 2026 Earnings EPS Surges Past Estimates as Cybersecurity Demand Remains Strong
DVLT Q1 2026 Earnings EPS Misses Estimates Stock Declines
SherwinWilliams SHW Q1 2026 Earnings Solid EPS Beat Amidst Mixed Demand Signals
VNET Q4 2025 Earnings Massive EPS Surprise of 296 Despite Revenue Uncertainty
Tenax Therapeutics TENX Faces Resistance Test After 186 Pullback From Recent Highs
Protalix BioTherapeutics PLX Rises 143 as Biotech Stock Tests Key Resistance
Hancock Whitney HWC Holds Steady Near Support as Volume Remains Light
Jyong Biotech MENS Remains RangeBound as Price Consolidates Near Support
ELPC Slips 126 Amid Resistance Test Key Levels for Companhia Paranaense de Energia